August 25, 2016
It is deplorable that innovative medicines are being seen as a “villain” for carrying high prices despite their benefits to patients and company efforts, Yoshiaki Kamoya, executive officer of Shionogi, said at a subcommittee meeting of the Central Social Insurance...read more